These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2868545)

  • 1. Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers--a thiol enhanced process.
    Procyk R; Adamson L; Block M; Blombäck B
    Thromb Res; 1985 Dec; 40(6):833-52. PubMed ID: 2868545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin.
    Procyk R; Blomback B
    Biochim Biophys Acta; 1988 Nov; 967(2):304-13. PubMed ID: 2903773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin. Effect of disulfide bond reduction on its physical and functional properties.
    Williams EC; Janmey PA; Johnson RB; Mosher DF
    J Biol Chem; 1983 May; 258(9):5911-4. PubMed ID: 6133874
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibronectin and fibrin gel structure.
    Okada M; Blombäck B; Chang MD; Horowitz B
    J Biol Chem; 1985 Feb; 260(3):1811-20. PubMed ID: 2857179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligation of fibrinogen by factor XIIIa with dithiothreitol: mechanical properties of ligated fibrinogen gels.
    Shimizu A; Ferry JD
    Biopolymers; 1988 Apr; 27(4):703-13. PubMed ID: 2897211
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor XIII cross-linking of fibronectin at cellular matrix assembly sites.
    Barry EL; Mosher DF
    J Biol Chem; 1988 Jul; 263(21):10464-9. PubMed ID: 2899077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
    Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M
    J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Aarhus and factor XIII induced polymerization and gel formation.
    Hessel B; Adamson L; Procyk R; Therkildsen L; Stenbjerg S; Blombäck B
    Br J Haematol; 1987 Jul; 66(3):355-61. PubMed ID: 3620354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators.
    Barsigian C; Stern AM; Martinez J
    J Biol Chem; 1991 Nov; 266(33):22501-9. PubMed ID: 1682320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of formation of factor XIIIa by its fibrin substrates.
    Lewis SD; Janus TJ; Lorand L; Shafer JA
    Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional comparisons of chicken and human cellular fibronectins.
    Bernard BA; Akiyama SK; Newton SA; Yamada KM; Olden K
    J Biol Chem; 1984 Aug; 259(15):9899-905. PubMed ID: 6146622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elastic modulus of fibrin clots and fibrinogen gels: the effect of fibronectin and dithiothreitol.
    Procyk R; King RG
    Biopolymers; 1990 Feb; 29(3):559-65. PubMed ID: 1970486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking of fibronectin to C-terminal fragments of the fibrinogen alpha-chain by factor XIIIa.
    Matsuka YV; Migliorini MM; Ingham KC
    J Protein Chem; 1997 Nov; 16(8):739-45. PubMed ID: 9365922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of factor XIIIa-mediated incorporation of fibronectin into fibrin by pulmonary surfactant.
    Elssner A; Mazur G; Vogelmeier C
    Am J Physiol; 1999 Apr; 276(4):L625-30. PubMed ID: 10198360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen.
    Bockenstedt P; McDonagh J; Handin RI
    J Clin Invest; 1986 Aug; 78(2):551-6. PubMed ID: 2874156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of formation of fibrin oligomers. III. Ligation kinetics concurrent with and subsequent to oligomer assembly.
    Bale MD; Janmey PA; Ferry JD; Lorand L
    Biopolymers; 1984 Jan; 23(1):127-38. PubMed ID: 6141816
    [No Abstract]   [Full Text] [Related]  

  • 19. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels.
    Carr ME; Gabriel DA; McDonagh J
    J Lab Clin Med; 1987 Dec; 110(6):747-52. PubMed ID: 2890701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.